Report cover image

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 16, 2075
Length 97 Pages
SKU # APRC20263562

Description

Summary

According to APO Research, The global Non-steroidal Anti-inflammatory Drugs (NSAID) market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Non-steroidal Anti-inflammatory Drugs (NSAID) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Non-steroidal Anti-inflammatory Drugs (NSAID) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Non-steroidal Anti-inflammatory Drugs (NSAID) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) include Merck Animal Health, Bayer, Zoetis, St. Joseph, Merial, Generic, Elanco, Ecotrin and Boehringer Ingelheim, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-steroidal Anti-inflammatory Drugs (NSAID), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-steroidal Anti-inflammatory Drugs (NSAID).

The Non-steroidal Anti-inflammatory Drugs (NSAID) market size, estimations, and forecasts are provided in terms of sales volume (W Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-steroidal Anti-inflammatory Drugs (NSAID) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Company

Merck Animal Health
Bayer
Zoetis
St. Joseph
Merial
Generic
Elanco
Ecotrin
Boehringer Ingelheim
Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Type

Propionic acid derivatives
Sulfonanilides
Anthranilic acid derivatives (Fenamates)
Salicylates
Enolic acid (Oxicam) derivatives
Selective COX-2 inhibitors (Coxibs)
Acetic acid derivatives
Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Application

Human
Animals
Others
Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-steroidal Anti-inflammatory Drugs (NSAID) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-steroidal Anti-inflammatory Drugs (NSAID) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-steroidal Anti-inflammatory Drugs (NSAID).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

97 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Estimates and Forecasts (2020-2031)
1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Type
1.3.1 Propionic acid derivatives
1.3.2 Sulfonanilides
1.3.3 Anthranilic acid derivatives (Fenamates)
1.3.4 Salicylates
1.3.5 Enolic acid (Oxicam) derivatives
1.3.6 Selective COX-2 inhibitors (Coxibs)
1.3.7 Acetic acid derivatives
1.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
1.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Overview by Type (2020-2031)
1.4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historic Market Size Review by Type (2020-2025)
1.4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2020-2025)
1.5.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2020-2025)
1.5.4 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Trends
2.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Drivers
2.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Opportunities and Challenges
2.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2020-2025)
3.2 Global Top Players by Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (2020-2025)
3.3 Global Top Players by Non-steroidal Anti-inflammatory Drugs (NSAID) Price (2020-2025)
3.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Major Company Production Sites & Headquarters
3.6 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Company, Product Type & Application
3.7 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Non-steroidal Anti-inflammatory Drugs (NSAID) Players Market Share by Revenue in 2024
3.8.3 2023 Non-steroidal Anti-inflammatory Drugs (NSAID) Tier 1, Tier 2, and Tier 3
4 Non-steroidal Anti-inflammatory Drugs (NSAID) Regional Status and Outlook
4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historic Market Size by Region
4.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Region (2020-2025)
4.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Value by Region (2020-2025)
4.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Market Size by Region
4.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Region (2026-2031)
4.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Value by Region (2026-2031)
4.3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Non-steroidal Anti-inflammatory Drugs (NSAID) by Application
5.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Application
5.1.1 Human
5.1.2 Animals
5.1.3 Others
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
5.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Overview by Application (2020-2031)
5.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historic Market Size Review by Application (2020-2025)
5.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application (2020-2025)
5.3.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application (2020-2025)
5.3.4 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Merck Animal Health
6.1.1 Merck Animal Health Comapny Information
6.1.2 Merck Animal Health Business Overview
6.1.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.1.5 Merck Animal Health Recent Developments
6.2 Bayer
6.2.1 Bayer Comapny Information
6.2.2 Bayer Business Overview
6.2.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.2.5 Bayer Recent Developments
6.3 Zoetis
6.3.1 Zoetis Comapny Information
6.3.2 Zoetis Business Overview
6.3.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.3.5 Zoetis Recent Developments
6.4 St. Joseph
6.4.1 St. Joseph Comapny Information
6.4.2 St. Joseph Business Overview
6.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.4.5 St. Joseph Recent Developments
6.5 Merial
6.5.1 Merial Comapny Information
6.5.2 Merial Business Overview
6.5.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.5.5 Merial Recent Developments
6.6 Generic
6.6.1 Generic Comapny Information
6.6.2 Generic Business Overview
6.6.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.6.5 Generic Recent Developments
6.7 Elanco
6.7.1 Elanco Comapny Information
6.7.2 Elanco Business Overview
6.7.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.7.5 Elanco Recent Developments
6.8 Ecotrin
6.8.1 Ecotrin Comapny Information
6.8.2 Ecotrin Business Overview
6.8.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.8.5 Ecotrin Recent Developments
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Comapny Information
6.9.2 Boehringer Ingelheim Business Overview
6.9.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments
7 North America by Country
7.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
7.1.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2020-2025)
7.1.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Country (2026-2031)
7.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
7.2.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country (2020-2025)
7.2.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
8.1.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2020-2025)
8.1.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Country (2026-2031)
8.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
8.2.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country (2020-2025)
8.2.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
9.1.1 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2020-2025)
9.1.3 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
9.2.1 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
10.1.1 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2020-2025)
10.1.3 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Country (2026-2031)
10.2 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
10.2.1 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country (2020-2025)
10.2.3 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
11.1.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2020-2025)
11.1.3 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
11.2.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Value Chain Analysis
12.1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Mode & Process
12.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors
12.2.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.